CHEK: חוב לטווח קצר להון עצמי Check-Cap Ltd.

Check-Cap Ltd. (CHEK) develops non-invasive capsules for the detection of intestinal tumors, leveraging Israeli innovations for global expansion. The price indicator on the GURU.Markets chart recorded a value of 0.00, which correlates with the current crisis. Expanding sales in Asia and Europe minimizes local risks, although the freezing of tests has led to restructuring and high costs associated with maintaining listing status.

This indicator compares liabilities with a maturity of up to one year against equity to determine the dependence of liquidity on current operating flows. A low short-term debt-to-equity ratio confirms the financial stability of Check-Cap Ltd. (CHEK) during the preparation for the commercial launch of its diagnostic capsule, minimizing the risk of a cash crunch before final regulatory approvals are obtained.